# Relative Bioavailability Study of SHR3680

> **NCT04903158** · PHASE1 · UNKNOWN · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 48 (actual)

## Conditions studied

- Healthy Male Subjects

## Interventions

- **DRUG:** test SHR3680 tablets
- **DRUG:** reference SHR3680 tablets

## Key facts

- **NCT ID:** NCT04903158
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-06
- **Primary completion:** 2021-03-15
- **Final completion:** 2021-05
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2021-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04903158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04903158, "Relative Bioavailability Study of SHR3680". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04903158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*